Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 4
2018 4
2019 7
2020 5
2021 4
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.
Santos-Gallego CG, Vargas-Delgado AP, Requena-Ibanez JA, Garcia-Ropero A, Mancini D, Pinney S, Macaluso F, Sartori S, Roque M, Sabatel-Perez F, Rodriguez-Cordero A, Zafar MU, Fergus I, Atallah-Lajam F, Contreras JP, Varley C, Moreno PR, Abascal VM, Lala A, Tamler R, Sanz J, Fuster V, Badimon JJ; EMPA-TROPISM (ATRU-4) Investigators. Santos-Gallego CG, et al. Among authors: garcia ropero a. J Am Coll Cardiol. 2021 Jan 26;77(3):243-255. doi: 10.1016/j.jacc.2020.11.008. Epub 2020 Nov 13. J Am Coll Cardiol. 2021. PMID: 33197559 Free article. Clinical Trial.
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics.
Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Ishikawa K, Watanabe S, Picatoste B, Flores E, Garcia-Ropero A, Sanz J, Hajjar RJ, Fuster V, Badimon JJ. Santos-Gallego CG, et al. Among authors: garcia ropero a. J Am Coll Cardiol. 2019 Apr 23;73(15):1931-1944. doi: 10.1016/j.jacc.2019.01.056. J Am Coll Cardiol. 2019. PMID: 30999996 Free article.
The anti-inflammatory effects of SGLT inhibitors.
García-Ropero Á, Santos-Gallego CG, Badimon JJ. García-Ropero Á, et al. Aging (Albany NY). 2019 Aug 25;11(16):5866-5867. doi: 10.18632/aging.102175. Epub 2019 Aug 25. Aging (Albany NY). 2019. PMID: 31449492 Free PMC article. No abstract available.
Saw-tooth cardiomyopathy: cardiomyopathies baring their teeth.
García-Ropero Á, Antonakaki D, Savvatis K. García-Ropero Á, et al. Rev Esp Cardiol (Engl Ed). 2022 Mar;75(3):261. doi: 10.1016/j.rec.2021.08.006. Epub 2021 Sep 2. Rev Esp Cardiol (Engl Ed). 2022. PMID: 34481751 English, Spanish. No abstract available.
Metabolism of the failing heart and the impact of SGLT2 inhibitors.
Garcia-Ropero A, Santos-Gallego CG, Zafar MU, Badimon JJ. Garcia-Ropero A, et al. Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):275-285. doi: 10.1080/17425255.2019.1588886. Epub 2019 Mar 11. Expert Opin Drug Metab Toxicol. 2019. PMID: 30822172 Review.
Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study.
Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Garcia-Ropero A, Ishikawa K, Watanabe S, Picatoste B, Vargas-Delgado AP, Flores-Umanzor EJ, Sanz J, Fuster V, Badimon JJ. Santos-Gallego CG, et al. Among authors: garcia ropero a. JACC Cardiovasc Imaging. 2021 Feb;14(2):393-407. doi: 10.1016/j.jcmg.2020.07.042. Epub 2020 Oct 29. JACC Cardiovasc Imaging. 2021. PMID: 33129742 Free article.
23 results